Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Metro G, Gariazzo E, Costabile S, Baglivo S, Roila F, Colamartini F, Palumbo B, Chiarini P, Gori S, Conti A, Marcomigni L, Bellezza G, Lunardi G. Metro G, et al. Among authors: chiarini p. Oncol Ther. 2024 Mar;12(1):173-174. doi: 10.1007/s40487-023-00258-z. Oncol Ther. 2024. PMID: 38170387 Free PMC article. No abstract available.
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Metro G, Gariazzo E, Costabile S, Baglivo S, Roila F, Colamartini F, Palumbo B, Chiarini P, Gori S, Conti A, Marcomigni L, Bellezza G, Lunardi G. Metro G, et al. Among authors: chiarini p. Oncol Ther. 2024 Mar;12(1):163-171. doi: 10.1007/s40487-023-00251-6. Epub 2023 Nov 16. Oncol Ther. 2024. PMID: 37973688 Free PMC article.
Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer.
Metro G, Chiari R, Ricciuti B, Rebonato A, Lupattelli M, Gori S, Bennati C, Castrioto C, Floridi P, Minotti V, Chiarini P, Crinò L. Metro G, et al. Among authors: chiarini p. Expert Opin Pharmacother. 2015;16(17):2601-13. doi: 10.1517/14656566.2015.1094056. Epub 2015 Oct 6. Expert Opin Pharmacother. 2015. PMID: 26439599
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis.
Metro G, Gili A, Signorelli D, De Toma A, Garaffa M, Galetta D, Economopoulou P, Friedlaender A, Jimenez B, Collazo-Lorduy A, Addeo A, Chiarini P, Costa C, Mountzios G, Roila F. Metro G, et al. Among authors: chiarini p. Clin Transl Oncol. 2021 Sep;23(9):1818-1826. doi: 10.1007/s12094-021-02588-8. Epub 2021 Mar 16. Clin Transl Oncol. 2021. PMID: 33728869
Changes of olfactory tract in Parkinson's disease: a DTI tractography study.
Nigro P, Chiappiniello A, Simoni S, Paolini Paoletti F, Cappelletti G, Chiarini P, Filidei M, Eusebi P, Guercini G, Santangelo V, Tarducci R, Calabresi P, Parnetti L, Tambasco N. Nigro P, et al. Among authors: chiarini p. Neuroradiology. 2021 Feb;63(2):235-242. doi: 10.1007/s00234-020-02551-4. Epub 2020 Sep 11. Neuroradiology. 2021. PMID: 32918150
48 results